Snake venom proteins acting on hemostasis

Iyaniwura, 1991, Snake venom constituents: biochemistry and toxicology (Part 2), Vet. Hum. Toxicol., 33, 475

Iyaniwura, 1991, Snake venom constituents: biochemistry and toxicology (Part 1), Vet. Hum. Toxicol., 33, 468

Marsh, 1994, Snake venoms affecting the haemostatic mechanism-a consideration of their mechanisms, practical applications and biological significance, Blood Coagul. Fibrinolysis, 5, 399

Samama, 1990

Davie, 1991, The coagulation cascade: initiation, maintenance, and regulation, Biochemistry, 30, 10363, 10.1021/bi00107a001

Harker, 1997, The role of platelets in the early and late vascular responses initiated by mechanical vascular injury, Fibrinolysis Proteolysis, 11, 97, 10.1016/S0268-9499(97)80031-8

Bjarnason, 1994, Hemorrhagic metalloproteinases from snake venoms, Pharmacol. Ther., 62, 325, 10.1016/0163-7258(94)90049-3

Kamiguti, 1998, Snake venom metalloproteinases and disintegrins: interactions with cells, Braz. J. Med. Biol. Res., 31, 853, 10.1590/S0100-879X1998000700001

Ouyang, 1983, Inhibition of platelet aggregation by 5’-nucleotidase purified from Trimeresurus gramineus snake venom, Toxicon, 21, 491, 10.1016/0041-0101(83)90127-7

Boffa, 1976, A phospholipase A2 with anticoagulant activity. II. Inhibition of the phospholipid activity in coagulation, Biochim. Biophys. Acta, 429, 839, 10.1016/0005-2744(76)90330-2

Kini, 1989, A model to explain the pharmacological effects of snake venom phospholipases A2, Toxicon, 27, 613, 10.1016/0041-0101(89)90013-5

Niewiarowski, 1994, Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors, Sem. Hematol., 31, 289

Kini, 1990, Effects of snake venom proteins on blood platelets, Toxicon, 28, 1387, 10.1016/0041-0101(90)90155-Z

Weinger, 1980, Prothrombin Houston: a dysprothrombin identifiable by crossed immunoelectrofocusing and abnormal Echis carinatus venom activation, Blood, 55, 811, 10.1182/blood.V55.5.811.811

Hardisty, 1966, Platelet aggregation and the availability of platelet factor 3, Br. J. Haemat., 12, 764, 10.1111/j.1365-2141.1966.tb00164.x

Quick, 1971, Thromboplastin generation: effect of the Bell-Alton reagent and Russell viper venom on prothrombin consumption, Am. J. Clin. Pathol., 55, 555, 10.1093/ajcp/55.5.555

Thiagarajan, 1986, The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant, Blood, 68, 869, 10.1182/blood.V68.4.869.869

Stocker, 1987, Characterization of the protein C activator Protac from the venom of the southern copperhead (Agkistrodon contortrix) snake, Toxicon, 25, 239, 10.1016/0041-0101(87)90253-4

Sharp, 1968, Anticoagulant therapy with a purified fraction of Malayan pit viper venom, Lancet, 1, 493, 10.1016/S0140-6736(68)91466-9

Stocker, 1976, The coagulant enzyme from Bothrops atrox venom (batroxobin), Methods Enzymol., 45, 214, 10.1016/S0076-6879(76)45021-8

Usami, 1993, Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca, Proc. Natl. Acad. Sci. USA, 90, 928, 10.1073/pnas.90.3.928

Siezen, 1999, Multi-domain, cell-envelope proteinases of lactic acid bacteria, Antonie van Leeuwenhoek Int. J. Gen. Mol. Microbiol., 76, 139, 10.1023/A:1002036906922

Rudenskaya, 1995, Macluralisin-a serine proteinase from fruits of Maclura pomifera (Raf.) Schneid, Planta, 196, 174, 10.1007/BF00193231

Neurath, 1984, Evolution of proteolytic enzymes, Science, 224, 350, 10.1126/science.6369538

Neurath, 1985, Proteolytic enzymes, past and present, Fed. Proc., 44, 2907

Perona, 1995, Structural basis of substrate specificity in the serine proteases, Prot. Sci., 4, 337, 10.1002/pro.5560040301

Neurath, 1984, Evolution of proteolytic enzymes, Science, 224, 350, 10.1126/science.6369538

Madison, 1989, Serpin-resistant mutants of human tissue-type plasminogen activator, Nature, 339, 721, 10.1038/339721a0

Matthews, 1967, Three-dimensional structure of tosyl-alpha-chymotrypsin, Nature, 214, 652, 10.1038/214652a0

Ruhlmann, 1973, Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region, J. Mol. Biol., 77, 417, 10.1016/0022-2836(73)90448-8

Bode, 1983, The X-ray structures of porcine pancreatic kallikrein and of its complex with bovine pancreatic trypsin inhibitor, Adv. Exp. Med. Biol., 156, 289

Bode, 1989, The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment, EMBO J., 8, 3467, 10.1002/j.1460-2075.1989.tb08511.x

Padmanabhan, 1993, Structure of human des(1-45) factor Xa at 2.2 A resolution, J. Mol. Biol., 232, 947, 10.1006/jmbi.1993.1441

Lamba, 1996, The 2.3 angstrom crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator, J. Mol. Biol., 258, 117, 10.1006/jmbi.1996.0238

Greer, 1990, Comparative modeling methods: application to the family of the mammalian serine proteases, Proteins, 7, 317, 10.1002/prot.340070404

Perona, 1997, Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold, J. Biol. Chem., 272, 29987, 10.1074/jbc.272.48.29987

Markland, 1997, Snake venoms, Drugs, 3, 1, 10.2165/00003495-199700543-00003

Mitrakul, 1979, Effect of five Thai snake venoms on coagulation, fibrinolysis and platelet aggregation, Southeast Asian J. Tropic. Med. Public Health, 10, 266

Marrakchi, 1995, Cerastocytin, a new thrombin-like platelet activator from the venom of the Tunisian viper Cerastes cerastes, Biochim. Biophys. Acta, 1244, 147, 10.1016/0304-4165(94)00216-K

Serrano, 1995, Purification, characterization, and amino acid sequence of a serine proteinase, PA-BJ, with platelet-aggregating activity from the venom of Bothrops jararaca, Biochemistry, 34, 7186, 10.1021/bi00021a033

Santos, 2000, Interaction of viper venom serine peptidases with thrombin receptors on human platelets, FEBS Lett., 477, 199, 10.1016/S0014-5793(00)01803-2

Kirby, 1979, Thrombocytin, a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme, Biochemistry, 18, 3564, 10.1021/bi00583a020

Kisiel, 1979, Molecular properties of the factor V-activating enzyme from Russell’s viper venom, J. Biol. Chem., 254, 12230, 10.1016/S0021-9258(19)86454-2

Stocker, 1982, Thrombin-like snake venom proteinases, Toxicon, 20, 265, 10.1016/0041-0101(82)90225-2

Pirkle, 1990, Thrombin-like venom enzymes: structure and function, Adv. Exp. Med. Biol., 281, 165, 10.1007/978-1-4615-3806-6_16

Pirkle, 1998, Thrombin-like enzymes from snake venoms: an updated inventory. Scientific and Standardization Committee’s Registry of Exogenous Hemostatic Factors, Thromb. Haemost., 79, 675, 10.1055/s-0037-1614965

Zhang, 1995, A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning, J. Biol. Chem., 270, 10246, 10.1074/jbc.270.17.10246

Itoh, 1988, Organization of the gene for batroxobin, a thrombin-like snake venom enzyme. Homology with the trypsin/kallikrein gene family, J. Biol. Chem., 263, 7628, 10.1016/S0021-9258(18)68544-8

Deshimaru, 1996, Accelerated evolution of Crotalinae snake venom gland serine proteases, FEBS Lett., 397, 83, 10.1016/S0014-5793(96)01144-1

Nakashima, 1993, Accelerated evolution of Trimeresurus flavoviridis venom gland phospholipase A2 isozymes, Proc. Natl. Acad. Sci. USA, 90, 5964, 10.1073/pnas.90.13.5964

Nakashima, 1995, Accelerated evolution in the protein-coding regions is universal in Crotalinae snake venom gland phospholipase A2 isozyme genes, Proc. Natl. Acad. Sci. USA, 92, 5605, 10.1073/pnas.92.12.5605

Ogawa, 1992, Unusually high conservation of untranslated sequences in cDNAs for Trimeresurus flavoviridis phospholipase A2 isozymes, Proc. Natl. Acad. Sci. USA, 89, 8557, 10.1073/pnas.89.18.8557

Parry, 1998, The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases, Structure, 6, 1195, 10.1016/S0969-2126(98)00119-1

Zhang, 1997, Trimeresurus stejnegeri snake venom plasminogen activator. Site-directed mutagenesis and molecular modeling, J. Biol. Chem., 272, 20531, 10.1074/jbc.272.33.20531

Collen, 1991, Basic and clinical aspects of fibrinolysis and thrombolysis, Blood, 78, 3114, 10.1182/blood.V78.12.3114.3114

Collen, 1988, Potential approaches for therapeutic intervention of thrombosis by fibrinolytic agents, Sem. Thromb. Hemost., 14, 95, 10.1055/s-2007-1002761

Fututake, 1988, Effects of defibrase on fibrinogen and its derivatives in patients with vibration syndrome, Vol. 7, 591

Braud, 2000, The contribution of residues 192 and 193 to the specificity of snake venom serine proteinases, J. Biol. Chem., 275, 1823, 10.1074/jbc.275.3.1823

Rosenberg, 1987, 534

Guillin, 1995, Thrombin specificity, Thromb. Haemost., 74, 129, 10.1055/s-0038-1642665

Tsiang, 1995, Functional mapping of the surface residues of human thrombin, J. Biol. Chem., 270, 16854, 10.1074/jbc.270.28.16854

Funk, 1971, Reptilase-R: a new reagent in blood coagulation, Br. J. Haematol., 21, 43, 10.1111/j.1365-2141.1971.tb03415.x

Matsuda, 1985, Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A, Thromb. Res., 37, 379, 10.1016/0049-3848(85)90067-2

Di Scipio, 1977, Activation of human factor X (Stuart factor) by a protease from Russell’s viper venom, Biochemistry, 16, 5253, 10.1021/bi00643a015

Takeya, 1992, Coagulation factor X-activating enzyme from Russell’s viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains, J. Biol. Chem., 267, 14109, 10.1016/S0021-9258(19)49685-3